[Comment] Access to respiratory syncytial virus preventive tools for neonates and infants in Europe
Respiratory syncytial virus (RSV) is responsible for an estimated 33 million cases of pneumonia and more than 100 000 deaths annually in children younger than 5 years.1 For the past two decades, the monoclonal antibody palivizumab has been the only ava...